NORTHERN TRUST CORP - TWIST BIOSCIENCE CORP ownership

TWIST BIOSCIENCE CORP's ticker is TWST and the CUSIP is 90184D100. A total of 195 filers reported holding TWIST BIOSCIENCE CORP in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TWIST BIOSCIENCE CORP
ValueSharesWeighting
Q3 2023$11,229,226
+0.0%
554,256
+1.0%
0.00%0.0%
Q2 2023$11,228,121
+42.9%
548,784
+5.3%
0.00%0.0%
Q1 2023$7,856,740
-35.4%
521,004
+2.0%
0.00%
-33.3%
Q4 2022$12,167,767
-32.8%
511,036
-0.5%
0.00%
-25.0%
Q3 2022$18,100,000
-0.1%
513,621
-0.9%
0.00%0.0%
Q2 2022$18,123,000
-28.4%
518,364
+1.1%
0.00%0.0%
Q1 2022$25,326,000
-29.9%
512,902
+9.8%
0.00%
-33.3%
Q4 2021$36,144,000
-28.9%
467,036
-1.7%
0.01%
-33.3%
Q3 2021$50,817,000
-24.5%
475,055
-6.0%
0.01%
-25.0%
Q2 2021$67,306,000
+5.4%
505,117
-2.0%
0.01%0.0%
Q1 2021$63,865,000
+5.2%
515,616
+19.9%
0.01%0.0%
Q4 2020$60,735,000
+83.2%
429,866
-1.5%
0.01%
+71.4%
Q3 2020$33,148,000
+78.1%
436,331
+6.2%
0.01%
+75.0%
Q2 2020$18,613,000
+78.8%
410,890
+20.7%
0.00%
+33.3%
Q1 2020$10,410,000
+73.7%
340,411
+19.3%
0.00%
+200.0%
Q4 2019$5,993,000
-11.6%
285,392
+0.5%
0.00%
-50.0%
Q3 2019$6,780,000
+80.0%
283,941
+118.6%
0.00%
+100.0%
Q2 2019$3,767,000
+117.9%
129,870
+74.1%
0.00%
Q1 2019$1,729,000
+7.7%
74,585
+7.3%
0.00%
Q4 2018$1,605,00069,5360.00%
Other shareholders
TWIST BIOSCIENCE CORP shareholders Q3 2020
NameSharesValueWeighting ↓
NanoDimension, Inc. 307,740$15,196,00033.32%
Tao Capital Management LP 828,815$40,927,00014.93%
Casdin Capital, LLC 880,000$43,454,0001.95%
BRANDYWINE MANAGERS, LLC 17,599$869,0001.50%
Jackson Square Partners, LLC 2,497,659$123,334,0001.22%
ARK Investment Management 5,264,255$259,949,0001.08%
Nicholas Investment Partners, LP 279,864$13,820,0000.98%
Lombard Odier Asset Management (Switzerland) SA 214,701$10,602,0000.83%
Nikko Asset Management Americas, Inc. 2,376,285$107,622,0000.79%
Capital Impact Advisors, LLC 15,340$757,0000.55%
View complete list of TWIST BIOSCIENCE CORP shareholders